The information is not available in the format requested. Such information as is available is shown in the following table.<\/p>
<\/p>
Estimated unit costs of a patient contact , 2012-13<\/p>
<\/p>
Type of patient contact<\/p><\/td> | Unit cost<\/p><\/td><\/tr> | ||||||
General practitioner (GP) consultation1<\/sup><\/p><\/td> £37<\/p><\/td><\/tr> First consultant-led appointment in an ophthalmology outpatient clinic2<\/sup><\/p><\/td> £108<\/p><\/td><\/tr> Accident and emergency attendance3<\/sup><\/p><\/td> £130<\/p><\/td><\/tr> Primary eyecare acute referral scheme<\/p><\/td> Not known<\/p><\/td><\/tr><\/tbody><\/table> <\/p> Notes:<\/em><\/p> 1<\/sup>The Department does not collect information on the unit cost of a GP consultation. An estimate of £37 per patient contact lasting 11.7 minutes, including direct care staff costs and excluding qualification costs, is included in page 198 of Unit Costs of Health and Social Care 2013 at www.pssru.ac.uk/project-pages/unit-costs/2013/. The data does not separately identify patients presenting with eye conditions or any other conditions.<\/p> <\/p> 2<\/sup>The average unit cost of first, face-to-face, consultant-led contacts in ophthalmology, medical ophthalmology and paediatric ophthalmology, weighted for activity. The information is from reference costs, which are the unit costs to NHS trusts and NHS foundation trusts of providing defined services in a given financial year to NHS patients, collected annually and published by the Department for 2012-13 at www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013<\/p> <\/p> 3<\/sup>The average unit of cost of accident and emergency attendances from 2012-13 reference costs. Includes attendances resulting in and not resulting in an admission. Excludes attendances submitted against Healthcare Resource Groups (HRGs) for Emergency Medicine, Dental Care (VB10Z) and Emergency Medicine, No Investigation with No Significant Treatment (VB11Z). The data does not separately identify patients presenting with eye conditions or any other conditions.<\/p> <\/p> Sources:<\/em><\/p> 2012/13 reference costs, Department of Health<\/p> Unit Costs of Health and Social Care 2013, Personal Social Services Research Unit<\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-06-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-06-11T15:43:52.2358305Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-06-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Eyesight: Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what estimate he has made of the costs of a patient who presents with eye conditions as a first point of call (a) a GP, (b) a hospital eye service, (c) an accident and emergency department and (d) a primary eyecare acute referral scheme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1552", "label" : {"_value" : "Biography information for Alison Seabeck"}
}
, "tablingMemberConstituency" : {"_value" : "Plymouth, Moor View"}
, "tablingMemberPrinted" : [{"_value" : "Alison Seabeck"}
], "uin" : "199248"}
, {"_about" : "http://data.parliament.uk/resources/58391", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/58391/answer", "answerText" : {"_value" : " Research infrastructure funded by the Department's National Institute for Health Research (NIHR) is currently hosting the following study:<\/p> <\/p> A multi-centre phase II trial to assess the efficacy of epirubicin, cisplatin and capecitabine in carcinomas of unknown primary: incorporating the prospective validation of molecular classifiers in diagnosis and classification and exploratory metabonomics.<\/p> <\/p> Overall NIHR investment in cancer research increased from £102 million in 2009-10 to £133 million in 2012-13. The NIHR welcomes funding applications for research into any aspect of human health, including cancer of unknown primary. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and the National Health Service, value for money and scientific quality.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-06-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-06-11T15:28:17.8346676Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-06-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to increase the amount of research undertaken into ways to detect the origin of primary cancer in those suffering from cancer of the unknown primary.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "199372"}
, {"_about" : "http://data.parliament.uk/resources/58392", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/58392/answer", "answerText" : {"_value" : " The Government has noted the report and is currently considering how to respond to the recommendations.<\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-06-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-06-10T15:23:48.5303857Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-06-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sunbeds"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, whether the Government plans to respond to the recommendations set out in the report of the All Party Parliamentary Group on Skin on sunbed regulation published in 2014.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "199381"}
, {"_about" : "http://data.parliament.uk/resources/58393", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/58393/answer", "answerText" : {"_value" : " We have not made any estimate of extending the human papillomavirus (HPV) vaccination programme to include boys aged 12 and 13 years, as the Joint Committee on Vaccination and Immunisation has not yet completed its consideration of whether HPV vaccine should be offered to males.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-06-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-06-10T14:44:56.5091119Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-06-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Human Papillomavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what estimate he has made of the potential cost of extending the human papilloma virus vaccination programme to include all boys aged 12 and 13 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "199382"}
, {"_about" : "http://data.parliament.uk/resources/58394", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/58394/answer", "answerText" : {"_value" : " Research in the evidence around the effectiveness of alcohol harm reduction communications and related campaigns suggests that labelling and point of sale information can have an impact on consumption, in conjunction with broader campaigns to raise consumer awareness and education on the health risks linked to alcohol consumption.<\/p> <\/strong><\/p> As part of the Public Health Responsibility Deal, alcohol retailers and producers have committed to putting an agreed warning or a pregnancy warning logo on 80% of labels on bottles and cans by the end of 2013. An independent market survey is underway to measure compliance. This level of coverage should allow the majority of consumers to see the pregnancy warning and logo.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-06-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-06-10T15:29:37.6664142Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-06-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pregnancy: Alcoholic Drinks"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what the Government's assessment is of the effectiveness of warning labels on alcoholic beverages regarding drinking during pregnancy; and what assessment he has made of the potential benefits of making such labels mandatory.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "199389"}
, {"_about" : "http://data.parliament.uk/resources/58395", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/58395/answer", "answerText" : {"_value" : " The information requested is not available.<\/p> <\/p> NHS England advises us that individual funding levels and programme costs vary between Academic Health Science Networks (AHSNs). NHS England budget allocations are not their sole source of income and AHSNs are seeking to supplement this funding through participation in strategic investment programmes and match-funding initiatives. Core running costs are for AHSNs to determine independently and may also be subject to change through the year.<\/p> <\/p> Further information on AHSN work programmes and business plans can be found on their websites:<\/p> <\/p> |